03 Dec News Coverage for Recent Psilocybin Studies
Heffter Research Institute is proud to have supported new psilocybin studies published December 1 in The Journal of Psychopharmacology reporting the effectiveness of using psilocybin to reduce depression, anxiety and existential distress in cancer patients. Below is a round-up of articles discussing the recent findings of the NYU School of Medicine and Johns Hopkins University studies.
- Hallucinogen Eases Depression in Cancer Patients, Studies Find – The New York Times
- Magic Mushroom Ingredient Psilocybin Can Lift Depression, Studies Show – The Guardian
- Just One Dose of this Psychedelic Drug Can Ease Anxiety – TIME
- There’s something in magic mushrooms that’s shown to ease anxiety and depression in cancer patients in one dose – Los Angeles Times
- Key Ingredient in ‘Magic Mushrooms’ Eased Cancer Patients’ Fear of Death – Washington Post
- Psychedelics reduce anxiety, depression in patients, study finds – Baltimore Sun
- The Life-Changing Magic of Mushrooms – The Atlantic
- ‘Magic Mushroom’ drug lifts cancer patients’ distress – USA Today
- Magic mushroom’ drug lifted ‘cloud of doom’ for cancer patients – CNN
- Psilocybin: A Journey Beyond the Fear of Death? – Scientific American
- Cancer Patients are Finding Anxiety Relief in Psychedelic Mushrooms – Huffington Post
- “Magic mushroom” psychedelic may ease depression, anxiety in cancer patients – CBS News
- Magic mushroom drug psilocybin helps cancer patients chill out – NBC News
- Treatment with hallucinogenic mushroom drug shows promise for patients with deep anxiety – PBS NewsHour
- Hallucinogenic Mushrooms May Be Beneficial for Cancer Patients – The TODAY Show
- Magic Mushrooms Show Promise In Easing Anxiety and Depression in Cancer Patients – Tech Times
- For Cancer Patients, Psilocybin Brings Much-Need Relief – Discover Magazine
- Magic Mushrooms are Weirdly Effective at Making Cancer Less Miserable – Gizmodo
- Shrooms Could Make Cancer Patients Less Terrified of Death – Vice
- Magic Mushroom Drug Helps People with Cancer Face Death – New Scientist
Have questions about psilocybin research? Contact Heffter Research Institute for more information.